Childhood immunisation against S. pneumoniae is the most effective public health measure for preventing IPD both among vaccine recipients (direct effect), and among unimmunised populations (indirect ‘herd’ effect).
EU case definition for diarrhoea and haemolytic uremic syndrome (HUS) caused by the epidemic strain Shiga toxin 2-producing Escherichia Coli (STEC) O104:H4
Public health advice on prevention of diarrhoeal illness with special focus on Shiga toxin - producing Escherichia coli (STEC), also called verotoxin - producing E. coli (VTEC) or enterohaemorrhagic E. coli (EHEC)
Outbreak of Shiga toxin - producing Escherichia coli (STEC), also called verotoxin-producing E. coli (VTEC) or enterohaemorrhagic E. coli (EHEC) in 2011
Ebola viruses and Marburg virus are classified as biosafety level 4 (BSL-4) pathogens and require special containment and barrier protection measures, in particular for people taking care of infected patients or bodies.
2014 was the first year that Ebola viral haemorrhagic fever infections were notified in TESSy, prompted by an outbreak in West Africa. Several, mostly travel-related, cases were reported in Europe since. Latest data from the Annual epidemiological report